Aduhelm

Analysis: US FDA faces mounting criticism over Alzheimer’s drug approval
World
June 11, 2021

Analysis: US FDA faces mounting criticism over Alzheimer’s drug approval

In approving the first new Alzheimer’s drug in nearly 20 years, the US Food and Drug Administration is taking its…
Back to top button